Karri Venn
Directeur Général chez hyperCORE International LLP
Profil
Karri Venn is currently the Chief Executive Officer at hyperCORE International LLP and the Chief Operating Officer at Centricity Research since 2022.
Previously, Ms. Venn worked as the Research Director at LMC Diabetes & Endocrinology Ltd.
Postes actifs de Karri Venn
| Sociétés | Poste | Début |
|---|---|---|
Centricity Research
 Centricity Research BiotechnologyHealth Technology Centricity Research is a clinical research organization that conducts clinical trials across therapeutic areas. The company is based in Columbus, GA and has subsidiaries in the United States. The CEO of the company is Jeffrey Kingsley. | Directeur des opérations | 01/01/2022 |
hyperCORE International LLP
 hyperCORE International LLP Miscellaneous Commercial ServicesCommercial Services hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn. | Directeur Général | - |
Anciens postes connus de Karri Venn
| Sociétés | Poste | Fin |
|---|---|---|
LMC Diabetes & Endocrinology Ltd.
 LMC Diabetes & Endocrinology Ltd. Hospital/Nursing ManagementHealth Services LMC Diabetes & Endocrinology Ltd. provides complete care in Diabetes, Endocrinology and Metabolism. It provides information on diabetes prevention, type 1 & diabetes, insulin pump therapy, treatment options and helps to overcome obstacles to meet diabetes targets. The firm enables wellness, embracing learning and expanding the therapeutic horizon is integrated into all aspects of centres. The company was founded by Ronnie Aronson in 1997 and is headquartered in Toronto, Canada. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
LMC Diabetes & Endocrinology Ltd.
LMC Diabetes & Endocrinology Ltd. Hospital/Nursing ManagementHealth Services LMC Diabetes & Endocrinology Ltd. provides complete care in Diabetes, Endocrinology and Metabolism. It provides information on diabetes prevention, type 1 & diabetes, insulin pump therapy, treatment options and helps to overcome obstacles to meet diabetes targets. The firm enables wellness, embracing learning and expanding the therapeutic horizon is integrated into all aspects of centres. The company was founded by Ronnie Aronson in 1997 and is headquartered in Toronto, Canada. | Health Services |
Centricity Research
Centricity Research BiotechnologyHealth Technology Centricity Research is a clinical research organization that conducts clinical trials across therapeutic areas. The company is based in Columbus, GA and has subsidiaries in the United States. The CEO of the company is Jeffrey Kingsley. | Health Technology |
hyperCORE International LLP
hyperCORE International LLP Miscellaneous Commercial ServicesCommercial Services hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn. | Commercial Services |
